Carsten Jäger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Carsten Jäger has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Ihsan Ekin Demir
Department of Surgery, Technical University of Munich, Munich, Germany
3 shared publications Helmut Friess
2 shared publications- Ilaria Pergolini
Department of Surgery TUM Universitätsklinikum Klinikum Rechts der Isar Technische Universität München Munich Germany
2 shared publications Alexander Muckenhuber
1 shared publication- Alexander Novotny
Department of Surgery, Technical University of Munich, TUM School of Medicine and Health, TUM University Hospital, Klinikum rechts der Isar, Munich, Germany
1 shared publication - Anneke Alkemade
Integrative Model-based Cognitive Neuroscience research unit, University of Amsterdam, Amsterdam, Netherlands
1 shared publication
Latest Publications
- Open Access
- 26 June 2025
- Published by Elsevier in Cancer Letters
- Vol. 630
Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy
- 26 June 2025
- Published by Elsevier in Cancer Letters
- Vol. 630
Open AccessPancreatic cancer cells survive in the neural niche during neoadjuvant therapy
- Open Access
Toward an early diagnostic marker of Parkinson’s: measuring iron in dopaminergic neurons with MR relaxometry
In Parkinson’s disease, the depletion of iron-rich dopaminergic neurons in nigrosome 1 of the substantia nigra precedes motor symptoms by two decades. Monitoring this neuronal depletion, at an early disease stage, is needed for early diagnosis. Magnetic resonance imaging (MRI) is particularly suitable for this task due to its sensitivity to iron. However, the exact mechanisms of MRI contrast in nigrosome 1 are not well understood, hindering the development of powerful biomarkers. We demonstrate that the dominant contribution to the effective transverse MRI relaxation rate in nigrosome 1 originates from iron accumulated in dopaminergic neurons. We link quantitatively to the product of cell density and local iron concentration in dopaminergic neurons, combining quantitative 3D iron histology, biophysical modeling, and quantitative MRI on post mortem brain tissue. It is now theoretically possible to monitor dopaminergic neuron depletion, in vivo , as an early diagnostic tool for Parkinson’s disease.
Open AccessToward an early diagnostic marker of Parkinson’s: measuring iron in dopaminergic neurons with MR relaxometry
In Parkinson’s disease, the depletion of iron-rich dopaminergic neurons in nigrosome 1 of the substantia nigra precedes motor symptoms by two decades. Monitoring this neuronal depletion, at an early disease stage, is needed for early diagnosis. Magnetic resonance imaging (MRI) is particularly suitable for this task due to its sensitivity to iron. However, the exact mechanisms of MRI contrast in nigrosome 1 are not well understood, hindering the development of powerful biomarkers. We demonstrate that the dominant contribution to the effective transverse MRI relaxation rate in nigrosome 1 originates from iron accumulated in dopaminergic neurons. We link quantitatively to the product of cell density and local iron concentration in dopaminergic neurons, combining quantitative 3D iron histology, biophysical modeling, and quantitative MRI on post mortem brain tissue. It is now theoretically possible to monitor dopaminergic neuron depletion, in vivo , as an early diagnostic tool for Parkinson’s disease.